Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression

The levels of circulating microparticles (MPs) are raised in various cardiovascular diseases. Their increased level in plasma is regarded as a biomarker of alteration in vascular function. The prominent MPs present in blood are endothelial microparticles (EMPs) described as complex submicron (0.1 to...

Full description

Saved in:
Bibliographic Details
Main Authors: Keshav Raj Paudel, Nisha Panth, Dong-Wook Kim
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Scientifica
Online Access:http://dx.doi.org/10.1155/2016/8514056
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560959096356864
author Keshav Raj Paudel
Nisha Panth
Dong-Wook Kim
author_facet Keshav Raj Paudel
Nisha Panth
Dong-Wook Kim
author_sort Keshav Raj Paudel
collection DOAJ
description The levels of circulating microparticles (MPs) are raised in various cardiovascular diseases. Their increased level in plasma is regarded as a biomarker of alteration in vascular function. The prominent MPs present in blood are endothelial microparticles (EMPs) described as complex submicron (0.1 to 1.0 μm) vesicles like structure, released in response to endothelium cell activation or apoptosis. EMPs possess both physiological and pathological effects and may promote oxidative stress and vascular inflammation. EMPs release is triggered by inducer like angiotensin II, lipopolysaccharide, and hydrogen peroxide leading to the progression of atherosclerosis. However, there are multiple physiological pathways for EMPs generation like NADPH oxidase derived endothelial ROS formation, Rho kinase pathway, and mitogen-activated protein kinases. Endothelial dysfunction is a key initiating event in atherosclerotic plaque formation. Atheroemboli, resulting from ruptured carotid plaques, is a major cause of stroke. Increasing evidence suggests that EMPs play an important role in the pathogenesis of cardiovascular disease, acting as a marker of damage, either exacerbating disease progression or triggering a repair response. In this regard, it has been suggested that EMPs have the potential to act as biomarkers of disease status. This review aims to provide updated information of EMPs in relation to atherosclerosis pathogenesis.
format Article
id doaj-art-9ed79c74adfe47eca99ea202267f016d
institution Kabale University
issn 2090-908X
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Scientifica
spelling doaj-art-9ed79c74adfe47eca99ea202267f016d2025-02-03T01:26:20ZengWileyScientifica2090-908X2016-01-01201610.1155/2016/85140568514056Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis ProgressionKeshav Raj Paudel0Nisha Panth1Dong-Wook Kim2Department of Oriental Medicine Resources, Mokpo National University, Muan-gun, Jeonnam 534-729, Republic of KoreaCollege of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Muan-gun, Jeonnam 58554, Republic of KoreaDepartment of Oriental Medicine Resources, Mokpo National University, Muan-gun, Jeonnam 534-729, Republic of KoreaThe levels of circulating microparticles (MPs) are raised in various cardiovascular diseases. Their increased level in plasma is regarded as a biomarker of alteration in vascular function. The prominent MPs present in blood are endothelial microparticles (EMPs) described as complex submicron (0.1 to 1.0 μm) vesicles like structure, released in response to endothelium cell activation or apoptosis. EMPs possess both physiological and pathological effects and may promote oxidative stress and vascular inflammation. EMPs release is triggered by inducer like angiotensin II, lipopolysaccharide, and hydrogen peroxide leading to the progression of atherosclerosis. However, there are multiple physiological pathways for EMPs generation like NADPH oxidase derived endothelial ROS formation, Rho kinase pathway, and mitogen-activated protein kinases. Endothelial dysfunction is a key initiating event in atherosclerotic plaque formation. Atheroemboli, resulting from ruptured carotid plaques, is a major cause of stroke. Increasing evidence suggests that EMPs play an important role in the pathogenesis of cardiovascular disease, acting as a marker of damage, either exacerbating disease progression or triggering a repair response. In this regard, it has been suggested that EMPs have the potential to act as biomarkers of disease status. This review aims to provide updated information of EMPs in relation to atherosclerosis pathogenesis.http://dx.doi.org/10.1155/2016/8514056
spellingShingle Keshav Raj Paudel
Nisha Panth
Dong-Wook Kim
Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression
Scientifica
title Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression
title_full Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression
title_fullStr Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression
title_full_unstemmed Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression
title_short Circulating Endothelial Microparticles: A Key Hallmark of Atherosclerosis Progression
title_sort circulating endothelial microparticles a key hallmark of atherosclerosis progression
url http://dx.doi.org/10.1155/2016/8514056
work_keys_str_mv AT keshavrajpaudel circulatingendothelialmicroparticlesakeyhallmarkofatherosclerosisprogression
AT nishapanth circulatingendothelialmicroparticlesakeyhallmarkofatherosclerosisprogression
AT dongwookkim circulatingendothelialmicroparticlesakeyhallmarkofatherosclerosisprogression